HEADER TRANSCRIPTION 23-SEP-19 6KZ5 TITLE CRYSTAL STRUCTURE ANALYSIS OF THE CSN-B-BOUNDED NUR77 LIGAND BINDING TITLE 2 DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A MEMBER 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: EARLY RESPONSE PROTEIN NAK1,NUCLEAR HORMONE RECEPTOR NUR/77, COMPND 5 NUR77,ORPHAN NUCLEAR RECEPTOR HMR,ORPHAN NUCLEAR RECEPTOR TR3,ST-59, COMPND 6 TESTICULAR RECEPTOR 3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR4A1, GFRP1, HMR, NAK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NR4A1, NUR77, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR W.HONG,H.CHEN,Q.WU,T.LIN REVDAT 4 22-NOV-23 6KZ5 1 REMARK REVDAT 3 18-NOV-20 6KZ5 1 JRNL REVDAT 2 04-NOV-20 6KZ5 1 JRNL REVDAT 1 14-OCT-20 6KZ5 0 JRNL AUTH P.B.YANG,P.P.HOU,F.Y.LIU,W.B.HONG,H.Z.CHEN,X.Y.SUN,P.LI, JRNL AUTH 2 Y.ZHANG,C.Y.JU,L.J.LUO,S.F.WU,J.X.ZHOU,Z.J.WANG,J.P.HE,L.LI, JRNL AUTH 3 T.J.ZHAO,X.DENG,T.LIN,Q.WU JRNL TITL BLOCKING PPAR GAMMA INTERACTION FACILITATES NUR77 JRNL TITL 2 INTERDICTION OF FATTY ACID UPTAKE AND SUPPRESSES BREAST JRNL TITL 3 CANCER PROGRESSION. JRNL REF PROC.NATL.ACAD.SCI.USA V. 117 27412 2020 JRNL REFN ESSN 1091-6490 JRNL PMID 33087562 JRNL DOI 10.1073/PNAS.2002997117 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.YANG,P.HOU,F.LIU,W.HONG,H.CHEN,X.SUN,P.LI,Y.ZHANG,C.JU, REMARK 1 AUTH 2 L.LUO,S.WU,J.ZHOU,Z.WANG,J.HE,L.LI,T.ZHAO,X.DENG,T.LIN,Q.WU REMARK 1 TITL BLOCKING PPAR GAMMA INTERACTION FACILITATES NUR77 REMARK 1 TITL 2 INTERDICTION OF FATTY ACID UPTAKE AND SUPPRESSES BREAST REMARK 1 TITL 3 CANCER PROGRESSION REMARK 1 REF PROC.NATL.ACAD.SCI.USA 2020 REMARK 1 REFN ESSN 1091-6490 REMARK 1 DOI 10.1073/PNAS.2002997117/-/DCSUPPLEMENTAL REMARK 1 REFERENCE 2 REMARK 1 AUTH Y.Y.ZHAN,Y.CHEN,Q.ZHANG,J.J.ZHUANG,M.TIAN,H.Z.CHEN, REMARK 1 AUTH 2 L.R.ZHANG,H.K.ZHANG,J.P.HE,W.J.WANG,R.WU,Y.WANG,C.SHI, REMARK 1 AUTH 3 K.YANG,A.Z.LI,Y.Z.XIN,T.Y.LI,J.Y.YANG,Z.H.ZHENG,C.D.YU, REMARK 1 AUTH 4 S.C.LIN,C.CHANG,P.Q.HUANG,T.LIN,Q.WU REMARK 1 TITL THE ORPHAN NUCLEAR RECEPTOR NUR77 REGULATES LKB1 REMARK 1 TITL 2 LOCALIZATION AND ACTIVATES AMPK. REMARK 1 REF NAT. CHEM. BIOL. V. 8 897 2012 REMARK 1 REFN ESSN 1552-4469 REMARK 1 PMID 22983157 REMARK 1 DOI 10.1038/NCHEMBIO.1069 REMARK 2 REMARK 2 RESOLUTION. 4.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 4.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.28 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 70.9 REMARK 3 NUMBER OF REFLECTIONS : 3241 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.249 REMARK 3 R VALUE (WORKING SET) : 0.246 REMARK 3 FREE R VALUE : 0.308 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 154 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 4.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 4.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : 168 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 52.29 REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE SET COUNT : 3 REMARK 3 BIN FREE R VALUE : 0.2240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3634 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.28000 REMARK 3 B22 (A**2) : -0.40000 REMARK 3 B33 (A**2) : -7.88000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.840 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.745 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3740 ; 0.005 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3635 ; 0.011 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5066 ; 1.049 ; 1.631 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8410 ; 1.434 ; 1.570 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 463 ; 5.814 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 183 ;35.240 ;21.202 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 648 ;17.841 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;16.373 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 474 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4109 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 783 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6KZ5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-OCT-19. REMARK 100 THE DEPOSITION ID IS D_1300012252. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-OCT-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97930 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : SDMS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4038 REMARK 200 RESOLUTION RANGE HIGH (A) : 4.450 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.2 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.14900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.5140 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 4.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 4.58 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.49200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3V3E REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS OF APO-LBD WAS OBTAINED AT 4 REMARK 280 DEGREES CELSIUS BY HANGING DROP VAPOR DIFFUSION. THE DROPLETS REMARK 280 CONSISTED OF A 1:1 (V/V) MIXTURE OF LBD AT 6 MG/ML, AND THE WELL REMARK 280 SOLUTION CONSISTED OF 100 MM SODIUM CITRATE (PH 4.6), 22% REMARK 280 GLYCEROL AND 5% PEG4000. CRYSTALS APPEARED AFTER 24-48 H AND REMARK 280 WERE READY FOR DATA COLLECTION IN 7 D., VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.29450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.86800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.04950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.86800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.29450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.04950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 19 REMARK 465 SER A 20 REMARK 465 LYS A 21 REMARK 465 PRO A 22 REMARK 465 LYS A 23 REMARK 465 GLN A 24 REMARK 465 PRO A 25 REMARK 465 PRO A 26 REMARK 465 ASP A 27 REMARK 465 ALA A 28 REMARK 465 SER A 29 REMARK 465 GLU A 214 REMARK 465 PRO A 215 REMARK 465 GLN A 216 REMARK 465 PRO A 217 REMARK 465 LEU A 268 REMARK 465 GLU A 269 REMARK 465 HIS A 270 REMARK 465 HIS A 271 REMARK 465 HIS A 272 REMARK 465 HIS A 273 REMARK 465 HIS A 274 REMARK 465 HIS A 275 REMARK 465 MET B 19 REMARK 465 SER B 20 REMARK 465 LYS B 21 REMARK 465 PRO B 22 REMARK 465 LYS B 23 REMARK 465 GLN B 24 REMARK 465 PRO B 25 REMARK 465 PRO B 26 REMARK 465 ASP B 27 REMARK 465 ALA B 28 REMARK 465 SER B 29 REMARK 465 PRO B 30 REMARK 465 ALA B 212 REMARK 465 GLY B 213 REMARK 465 GLU B 214 REMARK 465 PRO B 215 REMARK 465 GLN B 216 REMARK 465 PRO B 217 REMARK 465 LEU B 268 REMARK 465 GLU B 269 REMARK 465 HIS B 270 REMARK 465 HIS B 271 REMARK 465 HIS B 272 REMARK 465 HIS B 273 REMARK 465 HIS B 274 REMARK 465 HIS B 275 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ALA B 31 CB REMARK 470 LYS B 50 CG CD CE NZ REMARK 470 GLN B 57 CD OE1 NE2 REMARK 470 PHE B 64 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 66 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B 161 NZ LYS B 227 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O PRO B 126 NE2 HIS B 185 3555 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 48 -61.49 -1.21 REMARK 500 LYS A 50 40.82 -103.44 REMARK 500 HIS A 63 90.21 -62.49 REMARK 500 GLU A 189 64.70 -109.94 REMARK 500 LYS B 50 48.50 -99.07 REMARK 500 SER B 54 8.20 -66.68 REMARK 500 LYS B 55 13.50 -143.93 REMARK 500 HIS B 63 70.59 -60.84 REMARK 500 LYS B 66 -135.47 -143.30 REMARK 500 TRP B 151 -50.01 -29.94 REMARK 500 GLU B 189 69.09 -119.37 REMARK 500 LEU B 247 -77.87 -52.67 REMARK 500 PRO B 266 4.72 -69.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E4L B 301 DBREF 6KZ5 A 20 267 UNP P22736 NR4A1_HUMAN 351 598 DBREF 6KZ5 B 20 267 UNP P22736 NR4A1_HUMAN 351 598 SEQADV 6KZ5 MET A 19 UNP P22736 INITIATING METHIONINE SEQADV 6KZ5 LEU A 268 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 GLU A 269 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS A 270 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS A 271 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS A 272 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS A 273 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS A 274 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS A 275 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 MET B 19 UNP P22736 INITIATING METHIONINE SEQADV 6KZ5 LEU B 268 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 GLU B 269 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS B 270 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS B 271 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS B 272 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS B 273 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS B 274 UNP P22736 EXPRESSION TAG SEQADV 6KZ5 HIS B 275 UNP P22736 EXPRESSION TAG SEQRES 1 A 257 MET SER LYS PRO LYS GLN PRO PRO ASP ALA SER PRO ALA SEQRES 2 A 257 ASN LEU LEU THR SER LEU VAL ARG ALA HIS LEU ASP SER SEQRES 3 A 257 GLY PRO SER THR ALA LYS LEU ASP TYR SER LYS PHE GLN SEQRES 4 A 257 GLU LEU VAL LEU PRO HIS PHE GLY LYS GLU ASP ALA GLY SEQRES 5 A 257 ASP VAL GLN GLN PHE TYR ASP LEU LEU SER GLY SER LEU SEQRES 6 A 257 GLU VAL ILE ARG LYS TRP ALA GLU LYS ILE PRO GLY PHE SEQRES 7 A 257 ALA GLU LEU SER PRO ALA ASP GLN ASP LEU LEU LEU GLU SEQRES 8 A 257 SER ALA PHE LEU GLU LEU PHE ILE LEU ARG LEU ALA TYR SEQRES 9 A 257 ARG SER LYS PRO GLY GLU GLY LYS LEU ILE PHE CYS SER SEQRES 10 A 257 GLY LEU VAL LEU HIS ARG LEU GLN CYS ALA ARG GLY PHE SEQRES 11 A 257 GLY ASP TRP ILE ASP SER ILE LEU ALA PHE SER ARG SER SEQRES 12 A 257 LEU HIS SER LEU LEU VAL ASP VAL PRO ALA PHE ALA CYS SEQRES 13 A 257 LEU SER ALA LEU VAL LEU ILE THR ASP ARG HIS GLY LEU SEQRES 14 A 257 GLN GLU PRO ARG ARG VAL GLU GLU LEU GLN ASN ARG ILE SEQRES 15 A 257 ALA SER CYS LEU LYS GLU HIS VAL ALA ALA VAL ALA GLY SEQRES 16 A 257 GLU PRO GLN PRO ALA SER CYS LEU SER ARG LEU LEU GLY SEQRES 17 A 257 LYS LEU PRO GLU LEU ARG THR LEU CYS THR GLN GLY LEU SEQRES 18 A 257 GLN ARG ILE PHE TYR LEU LYS LEU GLU ASP LEU VAL PRO SEQRES 19 A 257 PRO PRO PRO ILE ILE ASP LYS ILE PHE MET ASP THR LEU SEQRES 20 A 257 PRO PHE LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 257 MET SER LYS PRO LYS GLN PRO PRO ASP ALA SER PRO ALA SEQRES 2 B 257 ASN LEU LEU THR SER LEU VAL ARG ALA HIS LEU ASP SER SEQRES 3 B 257 GLY PRO SER THR ALA LYS LEU ASP TYR SER LYS PHE GLN SEQRES 4 B 257 GLU LEU VAL LEU PRO HIS PHE GLY LYS GLU ASP ALA GLY SEQRES 5 B 257 ASP VAL GLN GLN PHE TYR ASP LEU LEU SER GLY SER LEU SEQRES 6 B 257 GLU VAL ILE ARG LYS TRP ALA GLU LYS ILE PRO GLY PHE SEQRES 7 B 257 ALA GLU LEU SER PRO ALA ASP GLN ASP LEU LEU LEU GLU SEQRES 8 B 257 SER ALA PHE LEU GLU LEU PHE ILE LEU ARG LEU ALA TYR SEQRES 9 B 257 ARG SER LYS PRO GLY GLU GLY LYS LEU ILE PHE CYS SER SEQRES 10 B 257 GLY LEU VAL LEU HIS ARG LEU GLN CYS ALA ARG GLY PHE SEQRES 11 B 257 GLY ASP TRP ILE ASP SER ILE LEU ALA PHE SER ARG SER SEQRES 12 B 257 LEU HIS SER LEU LEU VAL ASP VAL PRO ALA PHE ALA CYS SEQRES 13 B 257 LEU SER ALA LEU VAL LEU ILE THR ASP ARG HIS GLY LEU SEQRES 14 B 257 GLN GLU PRO ARG ARG VAL GLU GLU LEU GLN ASN ARG ILE SEQRES 15 B 257 ALA SER CYS LEU LYS GLU HIS VAL ALA ALA VAL ALA GLY SEQRES 16 B 257 GLU PRO GLN PRO ALA SER CYS LEU SER ARG LEU LEU GLY SEQRES 17 B 257 LYS LEU PRO GLU LEU ARG THR LEU CYS THR GLN GLY LEU SEQRES 18 B 257 GLN ARG ILE PHE TYR LEU LYS LEU GLU ASP LEU VAL PRO SEQRES 19 B 257 PRO PRO PRO ILE ILE ASP LYS ILE PHE MET ASP THR LEU SEQRES 20 B 257 PRO PHE LEU GLU HIS HIS HIS HIS HIS HIS HET E4L B 301 23 HETNAM E4L ETHYL 2-[2-OCTANOYL-3,5-BIS(OXIDANYL)PHENYL]ETHANOATE HETSYN E4L ETHYL 2-(3,5-DIHYDROXY-2-OCTANOYLPHENYL)ACETATE FORMUL 3 E4L C18 H26 O5 HELIX 1 AA1 ALA A 31 ASP A 43 1 13 HELIX 2 AA2 SER A 47 LEU A 51 5 5 HELIX 3 AA3 ASP A 68 LEU A 78 1 11 HELIX 4 AA4 LEU A 79 GLU A 91 1 13 HELIX 5 AA5 SER A 100 SER A 124 1 25 HELIX 6 AA6 ARG A 141 GLY A 149 1 9 HELIX 7 AA7 ASP A 150 SER A 164 1 15 HELIX 8 AA8 ASP A 168 ILE A 181 1 14 HELIX 9 AA9 GLU A 189 ALA A 212 1 24 HELIX 10 AB1 SER A 219 GLY A 226 1 8 HELIX 11 AB2 LEU A 228 ASP A 249 1 22 HELIX 12 AB3 PRO A 254 LEU A 265 1 12 HELIX 13 AB4 ASN B 32 ASP B 43 1 12 HELIX 14 AB5 ASP B 68 GLY B 81 1 14 HELIX 15 AB6 SER B 82 LYS B 92 1 11 HELIX 16 AB7 SER B 100 SER B 124 1 25 HELIX 17 AB8 ARG B 141 GLY B 149 1 9 HELIX 18 AB9 ASP B 150 SER B 164 1 15 HELIX 19 AC1 ASP B 168 ILE B 181 1 14 HELIX 20 AC2 GLU B 189 VAL B 211 1 23 HELIX 21 AC3 SER B 219 GLY B 226 1 8 HELIX 22 AC4 LYS B 227 ASP B 249 1 23 HELIX 23 AC5 PRO B 254 LEU B 265 1 12 SHEET 1 AA1 2 LYS A 130 ILE A 132 0 SHEET 2 AA1 2 VAL A 138 HIS A 140 -1 O LEU A 139 N LEU A 131 SHEET 1 AA2 2 LYS B 130 ILE B 132 0 SHEET 2 AA2 2 VAL B 138 HIS B 140 -1 O LEU B 139 N LEU B 131 SITE 1 AC1 4 ASP A 150 ASP B 150 ARG B 241 TYR B 244 CRYST1 74.589 76.099 127.736 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013407 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013141 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007829 0.00000